Literature DB >> 33585371

Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission.

Stefano Turolo1, Alberto C Edefonti1, William Morello1, Marie-Louise Syren2, Valentina De Cosmi2,3, Luciana Ghio1, Chiara Tamburello1, Erika A Demarco4, Alfredo Berrettini4, Gianantonio Manzoni4, Carlo Agostoni2,3, Giovanni Montini1,2.   

Abstract

Steroid-sensitive nephrotic syndrome is an immunological disorder mediated by still poorly defined circulating factor(s) that target the podocyte and damage the filtration barrier. Fatty acids (FA) have several biological roles and, in particular, are strictly involved in cell to cell communication, inflammatory processes and regulation of lymphocyte pools. Studies of FAs during INS have been mainly focused on biochemical changes during the phase of proteinuria; while no information is available about FA profile in patients with idiopathic nephrotic syndrome (INS) on stable remission. Aim of this study is to assess differences in blood FA profile between pediatric patients with INS during the phase of stable remission. Blood fatty acid profile of 47 pediatric patients on stable remission and 47 matched healthy controls were evaluated with gas chromatography. Patients with INS on stable remission had significantly higher levels of PUFA and omega-6 than controls (40.17 vs. 37.91% and 36.95 vs. 34.79%), lower levels of SFA and MUFA. Considering the single fatty acids, levels of omega-6 18:2n6 linoleic acid and omega-6 20:4n6 arachidonic acid were significantly higher in patients with INS than in controls (23.01 vs. 21.55%, p-value 0.003 and 10.37 vs. 9.65%, p-value 0.01). Moreover, patients with INS showed lower levels of SFA 14:0 (0.74 vs. 0.92%) and 18:0 (10.74 vs. 11.74%) and MUFA 18:1n9 oleic acid (18.50 vs. 19.83%). To the best of our knowledge this is the first study assessing FAs profile in children with INS in stable remission. In a population of 47 patients, we were able to demonstrate a higher blood level of linoleic and arachidonic acid, and consequently of omega-6 and PUFA, compared to controls. Persistently higher than normal levels of either linoleic or arachidonic acid, could be viewed as candidate biomarker for a state of risk of relapse in children with idiopathic nephrotic syndrome.
Copyright © 2021 Turolo, Edefonti, Morello, Syren, De Cosmi, Ghio, Tamburello, Demarco, Berrettini, Manzoni, Agostoni and Montini.

Entities:  

Keywords:  arachidonic acids; fatty acids (FA); idiopathic nephrotic syndrome (INS); omega-6 (ω-6) PUFA; stable remission

Year:  2021        PMID: 33585371      PMCID: PMC7875014          DOI: 10.3389/fped.2020.633470

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  33 in total

Review 1.  Arachidonic acid as a bioactive molecule.

Authors:  A R Brash
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

3.  The fatty acid profiles in a drop of blood from a fingertip correlate with physiological, dietary and lifestyle parameters in volunteers.

Authors:  F Marangoni; C Colombo; A Martiello; E Negri; C Galli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-01-05       Impact factor: 4.006

Review 4.  Recent advances in functional analysis of polyunsaturated fatty acid synthases.

Authors:  Shohei Hayashi; Yasuharu Satoh; Yasushi Ogasawara; Tohru Dairi
Journal:  Curr Opin Chem Biol       Date:  2020-05-19       Impact factor: 8.822

Review 5.  Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources.

Authors:  Francisca Echeverría; Rodrigo Valenzuela; María Catalina Hernandez-Rodas; Alfonso Valenzuela
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-08-14       Impact factor: 4.006

Review 6.  Eicosanoid and Specialized Proresolving Mediator Regulation of Lymphoid Cells.

Authors:  Jessica Wei; Karsten Gronert
Journal:  Trends Biochem Sci       Date:  2018-11-23       Impact factor: 13.807

7.  Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.

Authors:  A Jamin; L Dehoux; C Dossier; M Fila; N Heming; R C Monteiro; G Deschênes
Journal:  Clin Exp Immunol       Date:  2015-09-30       Impact factor: 4.330

8.  T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome.

Authors:  Fábio Tadeu Lourenço Guimarães; Gustavo Eustáquio Brito Alvim de Melo; Thiago Macedo Cordeiro; Victor Feracin; Etel Rocha Vieira; Wagner de Fátima Pereira; Sérgio Veloso Brant Pinheiro; Aline Silva Miranda; Ana Cristina Simões-E-Silva
Journal:  J Pediatr (Rio J)       Date:  2017-09-28       Impact factor: 2.197

Review 9.  The Search for Biomarkers to Aid in Diagnosis, Differentiation, and Prognosis of Childhood Idiopathic Nephrotic Syndrome.

Authors:  Hillarey Stone; Bliss Magella; Michael R Bennett
Journal:  Front Pediatr       Date:  2019-10-16       Impact factor: 3.418

Review 10.  Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease.

Authors:  Oh Yoen Kim; Su Mi Lee; Won Suk An
Journal:  Nutrients       Date:  2018-10-07       Impact factor: 5.717

View more
  1 in total

1.  Adherence to the Mediterranean Diet Improves Fatty Acids Profile in Pediatric Patients with Idiopathic Nephrotic Syndrome.

Authors:  Turolo Stefano; Edefonti Alberto; Morello William; Bolzan Giulia; Syren M Louise; Tamburello Chiara; Agostoni Carlo; Montini Giovanni
Journal:  Nutrients       Date:  2021-11-16       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.